Table 1 RECIST 1.1 and PERCIST 1.0 criteria for therapeutic response evaluation [10]

Responders

CR Disappearance of target lesions

CMR The target lesion shows absent FDG uptake or shows SUL_peak less than the liver.

PR ≥ 30% decrease in the sum of the diameter of the target lesions

PMR ≥ 30% decrease or at least 0.8 SUL_peak decrease

Non responders

SD Increase in size < 20% or decrease size < 30%

SMD Increase or decrease in the SUL_peak of less than 30%

PD ≥ 20% increase in the sum of the diameter of the target lesions or newly developed lesions

PMD The target lesion shows an increase in SUL_peak > 30% or at least 0.8 SUL_peak increase or newly developed lesions.